{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:46:03Z","timestamp":1786981563281,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11060-015-1766-5","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T20:10:22Z","timestamp":1428696622000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Survival prediction in high-grade gliomas using CT perfusion imaging"],"prefix":"10.1007","volume":"123","author":[{"name":"The Project of Emilia-Romagna Region on Neuro-Oncology (PERNO) Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Pok Chi","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Urbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gaf\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ulazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slav","family":"Yartsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"1766_CR1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492\u2013507","journal-title":"N Engl J Med"},{"key":"1766_CR2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","volume":"85","author":"WJ Curran","year":"1993","unstructured":"Curran WJ, Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704\u2013710","journal-title":"J Natl Cancer Inst"},{"issue":"suppl iv","key":"1766_CR3","first-page":"100","volume":"14","author":"M Weller","year":"2012","unstructured":"Weller M, Stupp R, Hegi ME et al (2012) Personalized care in neuro-oncology coming of age: why we need MGMT and 1p\/19q testing for malignant glioma patients in clinical practice. Neuro Oncol 14(suppl iv):100\u2013108","journal-title":"Neuro Oncol"},{"key":"1766_CR4","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"1766_CR5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3174\/ajnr.A2640","volume":"33","author":"M Essig","year":"2012","unstructured":"Essig M, Anzalone N, Combs SE et al (2012) MR imaging of neoplastic central nervous system lesions: Review and recommendations for current practice. Am J Neuroradiol 33:803\u2013817","journal-title":"Am J Neuroradiol"},{"key":"1766_CR6","first-page":"475","volume":"27","author":"S Cha","year":"2006","unstructured":"Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. Am J Neuroradiol 27:475\u2013487","journal-title":"Am J Neuroradiol"},{"key":"1766_CR7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3174\/ajnr.A0899","volume":"29","author":"R Jain","year":"2008","unstructured":"Jain R, Ellika SK, Scarpace L et al (2008) Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. Am J Neuroradiol 29:694\u2013700","journal-title":"Am J Neuroradiol"},{"key":"1766_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/RLI.0b013e3181ec9db0","volume":"45","author":"MA Weber","year":"2010","unstructured":"Weber MA, Henze M, T\u00fcttenberg J et al (2010) Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Invest Radiol 45:755\u2013768","journal-title":"Invest Radiol"},{"key":"1766_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3174\/ajnr.A2280","volume":"32","author":"R Jain","year":"2011","unstructured":"Jain R, Gutierrez J, Narang J et al (2011) In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas. Am J Neuroradiol 32:388\u2013394","journal-title":"Am J Neuroradiol"},{"key":"1766_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3174\/ajnr.A2743","volume":"33","author":"LS Hu","year":"2012","unstructured":"Hu LS, Eschbacher JM, Dueck AC et al (2012) Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. Am J Neuroradiol 33:69\u201376","journal-title":"Am J Neuroradiol"},{"key":"1766_CR11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.acra.2012.11.011","volume":"20","author":"R Jain","year":"2013","unstructured":"Jain R, Narang J, Griffith B et al (2013) Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates. Acad Radiol 20:478\u2013485","journal-title":"Acad Radiol"},{"key":"1766_CR12","doi-asserted-by":"crossref","first-page":"W504","DOI":"10.2214\/AJR.12.8967","volume":"200","author":"JJ Shankar","year":"2013","unstructured":"Shankar JJ, Woulfe J, Silva VD, Nguyen TB (2013) Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study. AJR Am J Roentgenol 200:W504\u2013W509","journal-title":"AJR Am J Roentgenol"},{"key":"1766_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.2472070898","volume":"247","author":"M Law","year":"2008","unstructured":"Law M, Young RJ, Babb JS et al (2008) Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247:490\u2013498","journal-title":"Radiology"},{"key":"1766_CR14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3174\/ajnr.A1465","volume":"30","author":"S Bisdas","year":"2009","unstructured":"Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z (2009) Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? Am J Neuroradiol 30:681\u2013688","journal-title":"Am J Neuroradiol"},{"key":"1766_CR15","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1158\/1078-0432.CCR-10-2098","volume":"17","author":"CJ Galb\u00e1n","year":"2011","unstructured":"Galb\u00e1n CJ, Chenevert TL, Meyer CR et al (2011) Prospective analysis of parametric response map-derived MRI biomarkers: Identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res 17:4751\u20134760","journal-title":"Clin Cancer Res"},{"key":"1766_CR16","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3174\/ajnr.A2263","volume":"32","author":"R Jain","year":"2011","unstructured":"Jain R (2011) Perfusion CT imaging of brain tumors: an overview. AJNR Am J Neuroradiol 32:1570\u20131577","journal-title":"AJNR Am J Neuroradiol"},{"key":"1766_CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00234-006-0120-1","volume":"48","author":"B Ding","year":"2006","unstructured":"Ding B, Ling HW, Chen KM, Jiang H, Zhu YB (2006) Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging. Neuroradiology 48:773\u2013781","journal-title":"Neuroradiology"},{"key":"1766_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-3-211-98811-4_53","volume":"106","author":"E Fainardi","year":"2010","unstructured":"Fainardi E, Di Biase F, Borrelli M et al (2010) Potential role of CT perfusion parameters in the identification of solitary intra-axial brain tumor grading. Acta Neurochir Suppl 106:283\u2013287","journal-title":"Acta Neurochir Suppl"},{"key":"1766_CR19","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3174\/ajnr.A0688","volume":"28","author":"SK Ellika","year":"2007","unstructured":"Ellika SK, Jain R, Patel SC et al (2007) Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. Am J Neuroradiol 28:1981\u20131987","journal-title":"Am J Neuroradiol"},{"key":"1766_CR20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3174\/ajnr.A2378","volume":"32","author":"R Jain","year":"2011","unstructured":"Jain R, Narang J, Schultz L et al (2011) Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: Can these add to other perfusion parameters in differentiating from recurrent\/progressive tumors? Am J Neuroradiol 32:658\u2013663","journal-title":"Am J Neuroradiol"},{"key":"1766_CR21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejrad.2011.02.068","volume":"81","author":"A Vidiri","year":"2012","unstructured":"Vidiri A, Guerrisi A, Pinzi V et al (2012) Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis? Eur J Radiol 81:1246\u20131252","journal-title":"Eur J Radiol"},{"key":"1766_CR22","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, My\u00f6h\u00e4nen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821\u20139826","journal-title":"Proc Natl Acad Sci USA"},{"key":"1766_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","volume":"118","author":"C Hartmann","year":"2009","unstructured":"Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469\u2013474","journal-title":"Acta Neuropathol"},{"key":"1766_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jmrs.37","volume":"61","author":"TPC Yeung","year":"2014","unstructured":"Yeung TPC, Yartsev Y, Lee TY et al (2014) Relationship of computed tomography perfusion and positron emission tomography to tumour progression in malignant glioma. J Med Radiat Sci 61:4\u201313","journal-title":"J Med Radiat Sci"},{"key":"1766_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.acra.2012.08.013","volume":"20","author":"TPC Yeung","year":"2013","unstructured":"Yeung TPC, Yartsev S, Bauman G, He W, Fainardi E, Lee TY (2013) The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors. Acad Radiol 20:59\u201365","journal-title":"Acad Radiol"},{"key":"1766_CR26","doi-asserted-by":"crossref","unstructured":"Pieper S, Lorensen B, Schroeder W, Kikinis R (2006) The NA-MIC Kit: ITK, VTK, pipelines, grids and 3D slicer as an open platform for the medical image computing community. In: Proceedings of the 3rd IEEE international symposium biomedical imaging: From Nano Macro, vol 1, pp 698\u2013701","DOI":"10.1109\/ISBI.2006.1625012"},{"key":"1766_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v035.i09","volume":"35","author":"D Rizopoulos","year":"2010","unstructured":"Rizopoulos D (2010) JM: an R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw 35:1\u201333","journal-title":"J Stat Softw"},{"key":"1766_CR28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610\u2013622","journal-title":"Nat Rev Neurosci"},{"key":"1766_CR29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","volume":"120","author":"M Kioi","year":"2010","unstructured":"Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM (2010) Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120:694\u2013705","journal-title":"J Clin Invest"},{"key":"1766_CR30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijrobp.2009.09.018","volume":"78","author":"MT Milano","year":"2010","unstructured":"Milano MT, Okunieff P, Donatello RS et al (2010) Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 78:1147\u20131155","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1766_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/RLI.0b013e31820e1511","volume":"46","author":"J V\u00f6glein","year":"2011","unstructured":"V\u00f6glein J, T\u00fcttenberg J, Weimer M et al (2011) Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure. Invest Radiol 46:390\u2013400","journal-title":"Invest Radiol"},{"key":"1766_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.10091440","volume":"256","author":"R Mangla","year":"2010","unstructured":"Mangla R, Singh G, Ziegelitz D et al (2010) Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology 256:575\u2013584","journal-title":"Radiology"},{"key":"1766_CR33","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1200\/JCO.2009.22.4998","volume":"27","author":"MJ Bent van den","year":"2009","unstructured":"van den Bent MJ, Vogelbaum MA, Wen PY, Macdonald DR, Chang SM (2009) End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol 27:2905\u20132908","journal-title":"J Clin Oncol"},{"key":"1766_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.surneu.2006.04.015","volume":"67","author":"MA Finn","year":"2007","unstructured":"Finn MA, Blumenthal DT, Salzman KL et al (2007) Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol 67:246\u2013250","journal-title":"Surg Neurol"},{"key":"1766_CR35","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.wnl.0000242894.21705.3c","volume":"67","author":"S Ulmer","year":"2006","unstructured":"Ulmer S, Braga TA, Barker FG 2nd et al (2006) Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 67:1668\u20131670","journal-title":"Neurology"},{"key":"1766_CR36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1148\/radiology.217.2.r00nv36377","volume":"217","author":"AJ Kumar","year":"2000","unstructured":"Kumar AJ, Leeds NE, Fuller GN et al (2000) Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217:377\u2013384","journal-title":"Radiology"},{"key":"1766_CR37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jmri.20335","volume":"21","author":"J Oh","year":"2005","unstructured":"Oh J, Cha S, Aiken AH et al (2005) Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 21:701\u2013708","journal-title":"J Magn Reson Imaging"},{"key":"1766_CR38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/neuonc\/not105","volume":"15","author":"E Hattingen","year":"2013","unstructured":"Hattingen E, Jurcoane A, Daneshvar K et al (2013) Quantitative T2 mapping of recurrent glioblastoma under Bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. Neuro Oncol 15:1395\u20131404","journal-title":"Neuro Oncol"},{"key":"1766_CR39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/neuonc\/noq194","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Lupo JM, Polley MY et al (2011) Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro Oncol 13:546\u2013557","journal-title":"Neuro Oncol"}],"updated-by":[{"DOI":"10.1007\/s11060-015-1946-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1766-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:22:49Z","timestamp":1559348569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1766-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]}}}